ILM1.DE

Medios AG [ILM1.DE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ILM1.DE Stock Summary

Top 10 Correlated ETFs

ILM1.DE

Top 10 Correlated Stocks

ILM1.DE

In the News

ILM1.DE Financial details

Company Rating
-
Market Cap
356.61M
Income
18.81M
Revenue
1.78B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
333
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
19.35
Forward P/E
-
PEG
74.5
P/S
0.2
P/B
0.78
P/C
-
P/FCF
12.78
Quick Ratio
1.84
Current Ratio
2.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.79
EPS next Y
-
EPS next Q
-
EPS this Y
2.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.35%
Revenue last 5Y
28.13%
Revenue Q/Q
-9.94%
EPS Q/Q
-66.67%
-
-
-
-
SMA20
-14.29%
SMA50
-20%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.06%
Gross Margin
6%
Oper. Margin
2%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13.34-20.25
52W High
-38.2%
52W Low
-4.92%
RSI
36
Rel Volume
0.7
Avg Volume
37.83K
Volume
26.56K
Perf Week
-0.8%
Perf Month
-7.21%
Perf Quarter
3%
Perf Half Y
0.98%
-
-
-
-
Beta
1.071
-
-
Volatility
0.08%, 0.8%
Prev Close
0.98%
Price
12.36
Change
0.65%

Something similar

Top by Market Cap
META
VFINX
EMBASSY.NS
1YD.DE
MSF.DE
Top Correlated ETFs
BTF
ETHW.SW
AETH.SW
MAXI
OBTC
Top Correlated Stocks
ETH
UOVEY
SCL
GLMD
MOGO
Similar Market Cap
600139.SS
AKW.PA
MG
9928.HK
CAC

Company Profile

Healthcare Medical - Distribution
  • Volume Average 37.83K
  • Market Capitalization 356.61M
  • Employee 333
  • CEO Mr. Matthias Gaertner
  • Headquarters Berlin,DE
  • IPO Date 2007-12-28
  • Website https://www.medios.ag

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.